Last Week in GER Research: Ascletis Pharma, China Tower, Pinduoduo, Beigene and CNFinance
Below is a recap of the key IPO research produced by the Global Equity Research team. This week we highlight our sensitivity analysis for Ascletis...
794 Views
Last Week in GER Research: Pindoudou, China Tower, Cango, Amazon, Aurora, Hope Ed., Ascletis and STX
Below is a recap of the key IPO research produced by the Global Equity Research team. This week we highlight bullish research on Pinduoduo,...
393 Views
Smartkarma: ECM Coverage Weekly Update (28 July 2018)
The Smartkarma ECM Team puts out a weekly update on the deals we have covered recently, along with updates for upcoming IPOs. Pinduoduo (PDD US)...
622 Views
China Tower Corp (中国铁塔) IPO: Fairly Valued For One Doing National Service
China Tower Co plans to raise as much as USD 8.6 billion to list in Hong Kong, at an implied market capitalization of USD 27.7 - 34.7 billion. We...
895 Views
China Tower IPO Valuation: Pay More to Get Less
China Tower (1409417D HK) has announced with a IPO price range of HK$1.26-HK$1.58 per share, raising US$6.8-US$8.8B (US$10B if greenshoe is...
761 Views